NCT06946797
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06946797
Title A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC) (CheckMate-1533)
Acronym CheckMate-1533
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ROU | POL | ITA | GRC | FRA | BRA

Facility Status City State Zip Country Details
Local Institution - 0032 Anchorage Alaska 99508 United States Details
Local Institution - 0062 Los Angeles California 90033 United States Details
Local Institution - 0063 Boise Idaho 83702 United States Details
Local Institution - 0052 Boise Idaho 83706 United States Details
Local Institution - 0064 Post Falls Idaho 83854 United States Details
Local Institution - 0047 Cleveland Ohio 44106 United States Details
Local Institution - 0033 Cleveland Ohio 44109 United States Details
Local Institution - 0051 Allentown Pennsylvania 18103 United States Details
Local Institution - 0041 Brasília Federal District 70200-730 Brazil Details
Local Institution - 0043 Belo Horizonte Minas Gerais 30380-490 Brazil Details
Local Institution - 0038 Porto Alegre Rio Grande do Sul 90035-903 Brazil Details
Local Institution - 0037 Barretos São Paulo 14784400 Brazil Details
Local Institution - 0034 São Paulo 01246-000 Brazil Details
Local Institution - 0067 Santiago Santiago Metropolitan 8420383 Chile Details
Local Institution - 0065 Dijon Côte-d'Or 21079 France Details
Local Institution - 0003 Suresnes Hauts-de-Seine 92151 France Details
Local Institution - 0010 Paris Île-de-France Region 75014 France Details
Local Institution - 0012 Athens Attikí 115 27 Greece Details
Local Institution - 0013 Chaïdári Attikí 12462 Greece Details
Local Institution - 0011 Thessaloniki Kentrikí Makedonía 540 07 Greece Details
Local Institution - 0014 Larissa Thessalía 41110 Greece Details
Local Institution - 0015 Meldola Emilia-Romagna 47014 Italy Details
Local Institution - 0057 Udine Friuli Venezia Giulia 33100 Italy Details
Local Institution - 0020 Bergamo Lombardy 24127 Italy Details
Local Institution - 0019 Florence Tuscany 50134 Italy Details
Local Institution - 0017 Novara 28100 Italy Details
Local Institution - 0081 Warsaw Masovian Voivodeship 03-411 Poland Details
Local Institution - 0080 Prabuty Pomeranian Voivodeship 82-550 Poland Details
Local Institution - 0079 Lodz Łódź Voivodeship 93-338 Poland Details
Local Institution - 0073 Bucharest Bucharest 022328 Romania Details
Local Institution - 0076 Florești Cluj 407280 Romania Details
Local Institution - 0077 Craiova Dolj 200542 Romania Details
Local Institution - 0075 Bucharest 020335 Romania Details
Local Institution - 0074 Cluj-Napoca 400015 Romania Details
Local Institution - 0078 Iași 700483 Romania Details
Local Institution - 0031 Soweto Gauteng 2013 South Africa Details
Local Institution - 0009 Sandton GP 2196 South Africa Details
Local Institution - 0084 Rondebosch Western Cape 7700 South Africa Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field